Infant Vaccine Study
Participants needed: Two month old infants
About pneumococcal disease
- Pneumococcal disease is caused by the bacteria Streptococcus pneumoniae.
- This bacteria can cause very severe infections such as bacteremia (blood poisoning), meningitis (brain infection) and pneumonia, and less severe infections like ear and sinus infections.
- Without vaccination, children under two years of age have the highest rates of disease.
What is the purpose of this study?
- The purpose of the study is to find out if two doses of pneumococcal vaccine (PCV) – Prevnar13®is as good as three doses (which is currently used in NS and most other provinces/territories in Canada) in protecting children against pneumococcal disease.
- We would like to find out if it is possible to achieve the same protection against pneumococcal infection using just two injections, at two and 12 months.
- This would reduce the number of needles needed for infants in the future, and result in significant cost savings across Canada.
Is my child eligible to participate?
- We are in need of healthy, two-month old infants.
- The study involves six visits over an 11-month period.
- Your child is seen at CCfV when your child is 2, 4, 5, 6, 12, and 13 months old.
- Visits will include three blood tests (total), routine vaccinations, physical exams, and questions about your baby’s health.
You will receive:
- Reimbursement for your out of pocket expenses related to the study such as travel and parking.
- Study staff will be giving all routine infant vaccinations up to 12 months of age.
- We will send documentation to you and to Public Health and record these vaccines on the child’s vaccination record.
Contact Pamela MacIntyre
Phone (902) 470-8948